UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of Principal Executive Offices)
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Item 2.01 Acquisition or Disposition of Assets
On March 20, 2024, Verde Bio Holdings, Inc. (the “Company”) announced that it had closed on a transaction of certain mineral and royalty interests (“Acquisition”) with a private buyer whereby the Company divested 100% of certain mineral and oil and gas royalty interests for $272,000 in cash, (“Purchase Price”). The acquisition closed on March 20, 2024, with the effective date of the acquisitions March 1, 2024.
A form of the Purchase Agreement is filed as Exhibit 10.1to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
Exhibits. The following exhibits are being filed herewith:
| Exhibit Number | Description of Exhibits | |
| 10.1 | Purchase and Sale Agreement | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 25th day of March, 2024.
| VERDE BIO HOLDINGS, INC. | |||
| By: | /s/ Scott A. Cox | ||
| Name: | Scott A. Cox | ||
| Title: | Chief Executive Officer | ||
2
Exhibit Index to Current Report on Form 8-K
| Exhibit Number | Description of Exhibits | |
| 10.1 | Purchase and Sale Agreement | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
3